Research project

ATTACK - Aspirin To Target Arterial Events in Chronic Kidney Disease

Research groups:
Other researchers:

Emeritus Professor Michael Moore,

Professor Joanne Lord
Research funder:

National Institute of Health and Care Research
Website:

http://www.southampton.ac.uk/attack-trial/index.page?
Status:

Active

Project overview

Does low-dose aspirin reduce the chance of a first heart attack or stroke in patients with chronic kidney disease (CKD)?

This multicentre randomised trial will assess the effectiveness of low dose aspirin to prevent cardiovascular disease (CVD) in adult patients with chronic kidney disease(CKD). There is uncertainty about the benefits (vs CVD) and harms (bleeding) of aspirin in such patients. CKD is common and the frequency is rising and it is associated with increased risk of CVD.

Staff

Other researchers

Emeritus Professor Michael Moore

Connect with Michael

Email: mvm198@soton.ac.uk

Professor Joanne Lord

Director of SHTAC

Research interests

Health economics
Cost-effectiveness analysis
Decision modelling

Connect with Joanne

Email: j.lord@soton.ac.uk

Collaborating research institutes, centres and groups

Primary Care Research Centre

We increase understanding of the psychosocial effects of cancer on daily life to improve health outcomes and help people live well.

Population Health Sciences

We research prevention of disease, reduction of health inequalities and optimisation of health and wellbeing for whole populations across the lifecourse, in the UK and internationally.

Research outputs

Aspirin for primary prevention of CVD in CKD: where do we stand?

Hugh G. Gallagher,

Mark Lown,

Ahmet Fuat,

& Paul Roderick

, 2019 , British Journal of General Practice , 69 (689) , 590--591

DOI: 10.3399/bjgp19X706661

Type: letterEditorial